A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

The Journal of Biological Chemistry
Eswar ShankarDavid Danielpour

Abstract

The transcription factor c-Fos controls many important cellular processes, including cell growth and apoptosis. c-Fos expression is rapidly elevated in the prostate upon castration-mediated androgen withdrawal through an undefined mechanism. Here we show that androgens (5α-dihydrotestosterone and R1881) suppress c-Fos protein and mRNA expression induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) or EGF in human prostate cancer (PCa) cell lines. Such suppression transpires through a transcriptional mechanism, predominantly at the proximal serum response element of the c-fos promoter. We show that androgen signaling suppresses TPA-induced c-Fos expression through repressing a PKC/MEK/ERK/ELK-1 signaling pathway. Moreover, our results support the hypothesis that p38(MAPK), PI3K, and PKCδ are involved in the androgenic regulation of c-Fos through controlling MEK/ERK. Stable silencing of c-Fos and PKCδ with shRNAs suggests that R1881 promotes cell death induced by low-dose TPA through a mechanism that is dependent on both PKCδ and loss of c-Fos expression. Reciprocally, loss of either PKCδ or c-Fos activates p38(MAPK) while suppressing the activation of ERK1/2. We also provide the first demonstration that R1881 permits cell death...Continue Reading

References

Jun 1, 1991·Endocrinology·P S CookeG R Cunha
Apr 1, 1990·Molecular and Cellular Biology·S J KimA B Roberts
Oct 1, 1994·Critical Reviews in Oncology/hematology·M Piechaczyk, J M Blanchard
Mar 19, 1993·Science·L M ObeidY A Hannun
Apr 1, 1996·Nucleic Acids Research·B V LatinkićL F Lau
Nov 29, 1996·Molecular and Cellular Endocrinology·G R Mora, V B Mahesh
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·Z T HanR L Chang
Jun 20, 1998·Molecular and Cellular Biology·D W KimB H Cochran
Nov 21, 1998·The Journal of Biological Chemistry·K FrønsdalF Saatcioglu
Mar 27, 1999·European Journal of Biochemistry·M Gschwendt
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·R ButtyanM Colombel
Apr 20, 2001·Cytokine & Growth Factor Reviews·P C SmithE T Keller
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·H K LinC Chang
Nov 15, 2001·The Journal of Biological Chemistry·Jerry E ChipukDavid Danielpour
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Apr 15, 2004·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
May 11, 2004·Biological & Pharmaceutical Bulletin·Judy Chia Ghee SngYukio Yoneda
Jun 11, 2005·Endocrine-related Cancer·Z CuligA Hobisch
Dec 20, 2005·The EMBO Journal·Kyung SongDavid Danielpour
Oct 3, 2007·Cancer Research·Xiaoping ZhangAria F Olumi
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaoping ZhangAria F Olumi

❮ Previous
Next ❯

Citations

May 18, 2016·International Journal of Molecular Sciences·Qiwei ChenJianbo Wang
Dec 29, 2020·OncoTargets and Therapy·Qiuyuan ZhuXu Zhang
Mar 2, 2021·Acta Pharmaceutica Sinica. B·Yifan ChenMeidan Ying

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis